In today’s episode, David Flores sits down with Dr. Ryan Westrum, the founder and visionary of Healing Souls, a practice dedicated to changing the way individuals, couples and families look at counseling.
In this episode, we talk about the fascinating psychedelic brews from ancient history. They question if our account of Christian history is correct, and even suggest that psychedelics are in part responsible for the very concept of communing with God.
In this episode of the Psychedelic Spotlight podcast, we speak…
In this video, I discuss how MindMed’s LSD Neutralizer is GENIUS: MindMed Stock’s Massive Opportunity (MMED/MMEDF. 🔥
MindMed has had a impressive run up in 2020. The MMED stock is up nearly 1,130% and what we all wonder is : Could MindMed Stock keep on rising? With a larger psychedelic pipeline than Compass Pathways (CMPS), MindMed has made huge advancements in 2020, one of which is its LSD Neutralizer Technology To Shorten and Stop LSD Trips, which is groundbreaking news for all players in the psychedelic medicines industry.
MindMed has a handful of exciting programs in the works, some of which have important milestones coming up this year. Project Lucy is one of these programs, using therapeutic doses of LSD to treat anxiety disorders. If this gets the go-ahead from regulators, it will proceed with a clinical trial investigating LSD for anxiety disorders. If that happens, the mindmed stock could get a big boost. Another boost could be MindMed’s potential uplisiting on to the Nasdaq.
Currently, the MindMed Stock trades on the Canadian exchange NEO under the symbol MMED. MindMed is also traded in the United States under the symbol MMEDF and in Germany under the symbol MMQ.
Remember to Like, Subscribe, and SMAH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
Follow us on social media!
Instagram: @psychedelicinvestor
Facebook: @thepsychedelicinvestor
Music: www.bensound.com
DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.
#MindMedStock #MindMed #MMED #MMEDF
The mental healthcare crisis is escalating: Are Psychedelic Medicines the Solution? Can psychedelics health North America fight against anxiety, depression and addiction?
It is well known that during these unprecedented times of lockdowns and fear, our society’s mental health has taken a toll. Unfortunately, few realize how dire the situation has become.
In some respects, this pandemic has accelerated other health care crises: such as the addiction and overdose crisis, the depression crisis, and the anxiety crisis.
These crises can be hard to see when the illnesses are often hidden by those that are experiencing them, out of shame.
However, we can’t start talking about solutions to the problem until we see how big the problem is.
Therefore, in this episode, we are going to take a look at:
1. Some of the data regarding addiction, depression, and anxiety levels during the pandemic, and show you how stark this increase has been;
2. We will discuss a novel solution which has a lot of evidence backing it up: using psychedelics like magic mushrooms and LSD to treat these maladies of the mind;
Enjoy the episode!
Timestamps:
0:00 – Intro
1:37 – Increased rates of Anxiety, Depression & Addiction in North America
6:24 – Psychedelic inspired medicines – potential solutions?
Follow us on social media! 🙌
Instagram: @thepsychedelicinvestor
Facebook: @thepsychedelicinvestor
Want to collaborate? Send us an email at:
thepsychedelicinvestor@gmail.com
Music from:
www.bensound.com
Video editing: @themyaholy
Check out our Benziga discounts
https://benzinga.grsm.io/jameshallifax1834
https://benzinga.grsm.io/thepsychedelicinvestor
Links:
Rates of addiction since the epidemic began:
https://www.kten.com/story/44309290/continued-increase-in-substance-abuse-after-pandemic
Rates of overdose:
https://www.google.com/url?q=https://www.forbes.com/sites/niallmccarthy/2021/07/16/us-experiences-a-historic-spike-in-overdose-deaths-infographic/?sh5452ed443650&sa=D&source=editors&ust=1626828792173000&usg=AOvVaw3NuNLOX7F8X_pg9Uh0Rnhv
Rates of depression:
https://www.meetfieldtrip.com/news/news-details/2021/More-than-80-of-Americans-report-one-or-more-symptoms-of-depression-and-many-have-turned-to-substances-to-cope-with-negative-emotions-during-COVID-19-Pandemic-according-to-Field-Trip-Healths-First-Annual-State-of-Mind-Survey/default.aspx
https://www.nature.com/articles/d41586-021-00175-z
Research into psychedelics as potential alternative treatments
Psilocybin: A potential treatment for depression:
https://newatlas.com/health-wellbeing/psilocybin-therapy-major-depression-trial-results-johns-hopkins/
https://www.imperial.ac.uk/news/219413/magic-mushroom-compound-performs-well-antidepressant/
Psilocybin : A potential cure for Smoking:
https://pubmed.ncbi.nlm.nih.gov/27441452/
Ibogaine: A potential cure for addiction:
https://www.tandfonline.com/doi/full/10.1080/00952990.2017.1310218
DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.
All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change.
#ANXIETY#DEPRESSION #PsychedelicTherapy
In this episode, journalist Ed Prideaux discusses Hallucinogen Persisting Perception Disorder and some of the other very real risks involved with psychedelic misuse.
This week on the Psychedelic Spotlight podcast, we provide a recap of the inaugural Benzinga Psychedelic Capital Conference which took place in Fontainebleau Miami Beach on April 19, 2022.
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.
